AT
CLX icon

Arlington Trust’s Clorox CLX Stock Holding History

Arlington Trust’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-59
Closed -$6.11K – 859
2026
Q1 		$6.11K Buy
+59
New +$6.69K ﹤0.01% 500

Other funds holding CLX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Arlington Trust's CLX Position: Q2 2026 in Review

Arlington Trust sold out of Clorox (CLX) in Q2 2026, closing a stake of 59 shares — an estimated $6.11K sold.

Arlington Trust first reported a position in CLX in Q1 2026 and held it in 1 quarter. The position peaked at $6.11K in Q1 2026. 1,039 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • Arlington Trust reported no remaining Clorox position as of Q2 2026 after selling out during the quarter.
  • Arlington Trust sold 59 Clorox shares in Q2 2026, an estimated $6.11K.
  • Arlington Trust first reported a position in Clorox in Q1 2026 and held it in 1 quarter.
  • Arlington Trust's Clorox position peaked at $6.11K in Q1 2026.
  • 1,039 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Arlington Trust's 13F filing for Q2 2026, filed 7 Jul 2026.